MedPath

Clinico-immunological Characterization and Immune Tolerance Breakdown in HU-autoimmunity

Active, not recruiting
Conditions
Immune Tolerance
Interventions
Other: Description of clinical, immunological and tumor features of patients harboring Hu Abs
Registration Number
NCT05745792
Lead Sponsor
Hospices Civils de Lyon
Brief Summary

Phenotypic characterization of patients with Hu-Abs, including the different neurological presentation and the presence or not of an underlying cancer.

Analysis and clinical correlation of the diagnostic techniques for Hu-Abs detection (immunofluorescence, immunodot/Western blot, and CBA) in serum and/or CSF.

Genomic and transcriptomic features of tumors (histological and immune infiltrate characteristics, transcriptomic profile, mutational status).

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
400
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Patients with Hu AbsDescription of clinical, immunological and tumor features of patients harboring Hu AbsPatients harboring Hu Abs and a neurological syndrome
Primary Outcome Measures
NameTimeMethod
Modified Rankin Scale (mRs)At 1 year

Application of modified rankin scale

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Centre de référence des syndromes neurologiques paranéoplasiques et encéphalites autoimmunes

🇫🇷

Lyon, France

© Copyright 2025. All Rights Reserved by MedPath